Strides Pharma Science submits press release

27 Aug 2019 Evaluate

Strides Pharma Science has informed about submission of press release issued by the Company titled: ‘Strides acquires USFDA approved manufacturing facility in the US’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

350.00 -7.90 (-2.21%)
Aug 19, 18:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 900.30
Cipla 1030.35
Dr. Reddys Lab 4199.95
Lupin 689.00
Zydus Lifesciences 387.65
View more..